Advertisement

Mutation Spectrum in a Large Cohort of Unrelated Chinese Patients With Hypertrophic Cardiomyopathy

      Hypertrophic cardiomyopathy (HC) is a hereditary heterogeneous cardiovascular disorder. Existing data have been of predominantly Caucasian samples, and a large study is needed in Chinese population. The present study was intended to explore the genetic basis and clinical characteristics correlated with different genotypes in a large cohort of Chinese patients. Direct gene sequencing of β-myosin heavy chain (MYH7), myosin binding protein-C (MYBPC3), and cardiac troponin T (TNNT2) was performed in 136 unrelated Chinese HC patients. Clinical evaluations were conducted. In total, 32 mutations were identified in 36 patients (27%), including 10 novel ones. Distribution of mutations was 56% (MYBPC3), 31% (MYH7), and 13% (TNNT2), respectively. Double mutations were identified in 3% patients. The occurrence of HC-associated sarcomeric mutations was associated with an earlier age of onset, increased left ventricular hypertrophy, a higher incidence of syncope, previous family history, and sudden cardiac death. No statistical difference was identified in patients carrying MYBPC3 and MYH7 mutations with regard to clinical characteristics and outcomes. Patients with double mutations were associated with malignant progression in the study. In conclusion, MYBPC3 is the most predominant gene in HC. Multiple mutations are common in MYH7, MYBPC3, and TNNT2. The present study suggests a large diversity of HC and a prognostic role of genotype.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Richardson P.
        • McKenna W.
        • Bristow M.
        • Maisch B.
        • Mautner B.
        • O’Connell J.
        • Olsen E.
        • Thiene G.
        • Goodwin J.
        • Gyarfas I.
        • Martin I.
        • Nordet P.
        Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
        Circulation. 1996; 93: 841-842
        • Maron B.J.
        • Epstein S.E.
        • Roberts W.C.
        Hypertrophic cardiomyopathy: a common cause of sudden death in the young competitive athlete.
        Eur Heart J. 1983; 4: 135-144
        • Towbin J.A.
        Molecular genetics of hypertrophic cardiomyopathy.
        Curr Cardiol Rep. 2000; 2: 134-140
        • Marian A.J.
        • Roberts R.
        The molecular genetic basis for hypertrophic cardiomyopathy.
        J Mol Cell Cardiol. 2001; 33: 655-670
        • Maron B.J.
        • Maron M.S.
        • Semsarian C.
        Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
        J Am Coll Cardiol. 2012; 60: 705-715
        • McKenna W.J.
        • Spirito P.
        • Desnos M.
        • Dubourg O.
        • Komajda M.
        Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.
        Heart. 1997; 77: 130-132
        • Ogino S.
        • Gulley M.L.
        • den Dunnen J.T.
        • Wilson R.B.
        Standard mutation nomenclature in molecular diagnostics: practical and educational challenges.
        J Mol Diagn. 2007; 9: 1-6
        • Xie W.L.
        • Liu W.L.
        • Hu D.Y.
        • Cui W.
        • Zhu T.G.
        • Li C.L.
        • Sun Y.H.
        • Li L.
        • Li T.C.
        • Bian H.
        • Tong Q.G.
        Zhonghua Yi Xue Za Zhi. 2004; 84 ([in Chinese]): 1610-1613
        • Pan G.Z.
        • Liu W.L.
        • Hu D.Y.
        • Xie W.L.
        • Zhu T.G.
        • Li L.
        • Li C.L.
        • Bian H.
        Zhonghua Yi Xue Za Zhi. 2006; 86 ([in Chinese]): 2998-3001
        • Richard P.
        • Charron P.
        • Carrier L.
        • Ledeuil C.
        • Cheav T.
        • Pichereau C.
        • Benaiche A.
        • Isnard R.
        • Dubourg O.
        • Burban M.
        • Gueffet J.P.
        • Millaire A.
        • Desnos M.
        • Schwartz K.
        • Hainque B.
        • Komajda M.
        Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
        Circulation. 2003; 107: 2227-2232
        • Van Driest S.L.
        • Ellsworth E.G.
        • Ommen S.R.
        • Tajik A.J.
        • Gersh B.J.
        • Ackerman M.J.
        Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy.
        Circulation. 2003; 108: 445-451
        • Van Driest S.L.
        • Jaeger M.A.
        • Ommen S.R.
        • Will M.L.
        • Gersh B.J.
        • Tajik A.J.
        • Ackerman M.J.
        Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2004; 44: 602-610
        • Van Driest S.L.
        • Ommen S.R.
        • Tajik A.J.
        • Gersh B.J.
        • Ackerman M.J.
        Sarcomeric genotyping in hypertrophic cardiomyopathy.
        Mayo Clin Proc. 2005; 80: 463-469
        • Song L.
        • Zou Y.
        • Wang J.
        • Wang Z.
        • Zhen Y.
        • Lou K.
        • Zhang Q.
        • Wang X.
        • Wang H.
        • Li J.
        • Hui R.
        Mutations profile in Chinese patients with hypertrophic cardiomyopathy.
        Clin Chim Acta. 2005; 351: 209-216
        • Van Driest S.L.
        • Vasile V.C.
        • Ommen S.R.
        • Will M.L.
        • Tajik A.J.
        • Gersh B.J.
        • Ackerman M.J.
        Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2004; 44: 1903-1910
        • Moolman J.C.
        • Corfield V.A.
        • Posen B.
        • Ngumbela K.
        • Seidman C.
        • Brink P.A.
        • Watkins H.
        Sudden death due to troponin T mutations.
        J Am Coll Cardiol. 1997; 29: 549-555
        • Marian A.J.
        • Roberts R.
        Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death.
        J Cardiovasc Electrophysiol. 1998; 9: 88-99
        • Ackerman M.J.
        • VanDriest S.L.
        • Ommen S.R.
        • Will M.L.
        • Nishimura R.A.
        • Tajik A.J.
        • Gersh B.J.
        Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.
        J Am Coll Cardiol. 2002; 39: 2042-2048
        • Anan R.
        • Greve G.
        • Thierfelder L.
        • Watkins H.
        • McKenna W.J.
        • Solomon S.
        • Vecchio C.
        • Shono H.
        • Nakao S.
        • Tanaka H.
        • Mares Jr., A.
        • Towbin J.A.
        • Spirito P.
        • Roberts R.
        • Seidman J.G.
        • Seidman C.E.
        Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
        J Clin Invest. 1994; 93: 280-285
        • Watkins H.
        • Rosenzweig A.
        • Hwang D.S.
        • Levi T.
        • McKenna W.
        • Seidman C.E.
        • Seidman J.G.
        Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.
        N Engl J Med. 1992; 326: 1108-1114
        • Hwang T.H.
        • Lee W.H.
        • Kimura A.
        • Satoh M.
        • Nakamura T.
        • Kim M.K.
        • Choi S.K.
        • Park J.E.
        Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family.
        Am J Cardiol. 1998; 82: 1509-1513
        • Olivotto I.
        • Girolami F.
        • Sciagra R.
        • Ackerman M.J.
        • Sotgia B.
        • Bos J.M.
        • Nistri S.
        • Sgalambro A.
        • Grifoni C.
        • Torricelli F.
        • Camici P.G.
        • Cecchi F.
        Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
        J Am Coll Cardiol. 2011; 58: 839-848
        • Niimura H.
        • Bachinski L.L.
        • Sangwatanaroj S.
        • Watkins H.
        • Chudley A.E.
        • McKenna W.
        • Kristinsson A.
        • Roberts R.
        • Sole M.
        • Maron B.J.
        • Seidman J.G.
        • Seidman C.E.
        Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
        N Engl J Med. 1998; 338: 1248-1257
        • Garcia-Castro M.
        • Coto E.
        • Reguero J.R.
        • Berrazueta J.R.
        • Alvarez V.
        • Alonso B.
        • Sainz R.
        • Martin M.
        • Moris C.
        [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].
        Rev Esp Cardiol. 2009; 62: 48-56
        • Girolami F.
        • Ho C.Y.
        • Semsarian C.
        • Baldi M.
        • Will M.L.
        • Baldini K.
        • Torricelli F.
        • Yeates L.
        • Cecchi F.
        • Ackerman M.J.
        • Olivotto I.
        Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
        J Am Coll Cardiol. 2010; 55: 1444-1453
        • Ingles J.
        • Doolan A.
        • Chiu C.
        • Seidman J.
        • Seidman C.
        • Semsarian C.
        Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling.
        J Med Genet. 2005; 42: e59
        • Kelly M.
        • Semsarian C.
        Multiple mutations in genetic cardiovascular disease: a marker of disease severity.
        Circ Cardiovasc Genet. 2009; 2: 182-190
        • Maron B.J.
        • Maron M.S.
        • Semsarian C.
        Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.
        Heart Rhythm. 2012; 9: 57-63
        • Liu S.X.
        • Hu S.J.
        • Sun J.
        • Wang J.
        • Wang X.T.
        • Jiang Y.
        • Cai J.
        Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.
        Eur J Intern Med. 2005; 16: 328-333